nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—ADRA1B—polycystic ovary syndrome	0.618	0.744	CbGaD
Azelastine—CYP1A1—polycystic ovary syndrome	0.212	0.256	CbGaD
Azelastine—CYP2C19—urine—polycystic ovary syndrome	0.00318	0.0829	CbGeAlD
Azelastine—CYP1A2—urine—polycystic ovary syndrome	0.0026	0.0677	CbGeAlD
Azelastine—CYP2C9—urine—polycystic ovary syndrome	0.00247	0.0643	CbGeAlD
Azelastine—CYP2E1—urine—polycystic ovary syndrome	0.00234	0.0609	CbGeAlD
Azelastine—CYP3A4—urine—polycystic ovary syndrome	0.00188	0.049	CbGeAlD
Azelastine—CYP2D6—urine—polycystic ovary syndrome	0.00185	0.0482	CbGeAlD
Azelastine—CYP2A6—adipose tissue—polycystic ovary syndrome	0.00105	0.0275	CbGeAlD
Azelastine—CYP2A6—vagina—polycystic ovary syndrome	0.000877	0.0228	CbGeAlD
Azelastine—KCNH2—endometrium—polycystic ovary syndrome	0.000718	0.0187	CbGeAlD
Azelastine—Loxapine—ADRA1B—polycystic ovary syndrome	0.00067	0.297	CrCbGaD
Azelastine—KCNH2—uterus—polycystic ovary syndrome	0.000662	0.0172	CbGeAlD
Azelastine—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.00066	0.0172	CbGeAlD
Azelastine—CYP2C8—endometrium—polycystic ovary syndrome	0.000657	0.0171	CbGeAlD
Azelastine—KCNH2—pituitary gland—polycystic ovary syndrome	0.00065	0.0169	CbGeAlD
Azelastine—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000595	0.0155	CbGeAlD
Azelastine—KCNH2—adrenal gland—polycystic ovary syndrome	0.000581	0.0151	CbGeAlD
Azelastine—HRH1—endometrium—polycystic ovary syndrome	0.000576	0.015	CbGeAlD
Azelastine—CYP2C19—vagina—polycystic ovary syndrome	0.000564	0.0147	CbGeAlD
Azelastine—Clozapine—ADRA1B—polycystic ovary syndrome	0.000563	0.249	CrCbGaD
Azelastine—CYP1A1—uterus—polycystic ovary syndrome	0.000559	0.0146	CbGeAlD
Azelastine—CYP1A1—adipose tissue—polycystic ovary syndrome	0.000547	0.0142	CbGeAlD
Azelastine—KCNH2—female gonad—polycystic ovary syndrome	0.000541	0.0141	CbGeAlD
Azelastine—KCNH2—vagina—polycystic ovary syndrome	0.000538	0.014	CbGeAlD
Azelastine—CYP3A5—adipose tissue—polycystic ovary syndrome	0.000535	0.0139	CbGeAlD
Azelastine—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000528	0.0138	CbGeAlD
Azelastine—HRH1—adipose tissue—polycystic ovary syndrome	0.000519	0.0135	CbGeAlD
Azelastine—KCNH2—endocrine gland—polycystic ovary syndrome	0.000503	0.0131	CbGeAlD
Azelastine—CYP2C8—vagina—polycystic ovary syndrome	0.000492	0.0128	CbGeAlD
Azelastine—CYP2B6—adrenal gland—polycystic ovary syndrome	0.000477	0.0124	CbGeAlD
Azelastine—HRH1—adrenal gland—polycystic ovary syndrome	0.000465	0.0121	CbGeAlD
Azelastine—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000461	0.012	CbGeAlD
Azelastine—CYP1A1—female gonad—polycystic ovary syndrome	0.000457	0.0119	CbGeAlD
Azelastine—CYP1A1—vagina—polycystic ovary syndrome	0.000454	0.0118	CbGeAlD
Azelastine—Loxapine—ADRA1A—polycystic ovary syndrome	0.000451	0.2	CrCbGaD
Azelastine—CYP2E1—adrenal gland—polycystic ovary syndrome	0.000447	0.0117	CbGeAlD
Azelastine—CYP3A5—female gonad—polycystic ovary syndrome	0.000447	0.0116	CbGeAlD
Azelastine—CYP3A5—vagina—polycystic ovary syndrome	0.000444	0.0116	CbGeAlD
Azelastine—CYP2B6—vagina—polycystic ovary syndrome	0.000442	0.0115	CbGeAlD
Azelastine—HRH1—female gonad—polycystic ovary syndrome	0.000434	0.0113	CbGeAlD
Azelastine—HRH1—vagina—polycystic ovary syndrome	0.000431	0.0112	CbGeAlD
Azelastine—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000431	0.0112	CbGeAlD
Azelastine—ABCB1—embryo—polycystic ovary syndrome	0.000431	0.0112	CbGeAlD
Azelastine—CYP1A1—endocrine gland—polycystic ovary syndrome	0.000425	0.0111	CbGeAlD
Azelastine—CYP3A5—endocrine gland—polycystic ovary syndrome	0.000416	0.0108	CbGeAlD
Azelastine—CYP2B6—endocrine gland—polycystic ovary syndrome	0.000413	0.0108	CbGeAlD
Azelastine—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000409	0.0107	CbGeAlD
Azelastine—HRH1—endocrine gland—polycystic ovary syndrome	0.000404	0.0105	CbGeAlD
Azelastine—CYP2E1—endocrine gland—polycystic ovary syndrome	0.000388	0.0101	CbGeAlD
Azelastine—Clozapine—ADRA1A—polycystic ovary syndrome	0.000379	0.168	CrCbGaD
Azelastine—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000353	0.00919	CbGeAlD
Azelastine—CYP2D6—female gonad—polycystic ovary syndrome	0.00033	0.0086	CbGeAlD
Azelastine—ABCB1—endometrium—polycystic ovary syndrome	0.000315	0.00821	CbGeAlD
Azelastine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000312	0.00813	CbGeAlD
Azelastine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000307	0.008	CbGeAlD
Azelastine—ABCB1—uterus—polycystic ovary syndrome	0.00029	0.00756	CbGeAlD
Azelastine—ABCB1—pituitary gland—polycystic ovary syndrome	0.000285	0.00743	CbGeAlD
Azelastine—ABCB1—adipose tissue—polycystic ovary syndrome	0.000284	0.0074	CbGeAlD
Azelastine—ABCB1—adrenal gland—polycystic ovary syndrome	0.000255	0.00664	CbGeAlD
Azelastine—ABCB1—female gonad—polycystic ovary syndrome	0.000237	0.00619	CbGeAlD
Azelastine—ABCB1—vagina—polycystic ovary syndrome	0.000236	0.00615	CbGeAlD
Azelastine—ABCB1—endocrine gland—polycystic ovary syndrome	0.000221	0.00575	CbGeAlD
Azelastine—Clozapine—CYP1A1—polycystic ovary syndrome	0.000193	0.0856	CrCbGaD
Azelastine—CYP2A6—Metabolism—CYP19A1—polycystic ovary syndrome	1.29e-05	0.0001	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	1.29e-05	9.99e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.29e-05	9.98e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	1.29e-05	9.97e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	1.28e-05	9.93e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	1.27e-05	9.88e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PGR—polycystic ovary syndrome	1.27e-05	9.88e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	1.26e-05	9.8e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	1.26e-05	9.79e-05	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.26e-05	9.78e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ATF1—polycystic ovary syndrome	1.25e-05	9.68e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	1.25e-05	9.66e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	1.24e-05	9.63e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	1.23e-05	9.58e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—AKR1C3—polycystic ovary syndrome	1.23e-05	9.57e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.22e-05	9.44e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CYP17A1—polycystic ovary syndrome	1.21e-05	9.42e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	1.21e-05	9.41e-05	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.21e-05	9.4e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	1.21e-05	9.36e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	1.21e-05	9.36e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.21e-05	9.35e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	1.2e-05	9.29e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	1.2e-05	9.28e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.19e-05	9.22e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.19e-05	9.22e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—GHRL—polycystic ovary syndrome	1.18e-05	9.18e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PLAT—polycystic ovary syndrome	1.18e-05	9.18e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	1.18e-05	9.18e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.18e-05	9.14e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.17e-05	9.08e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	1.17e-05	9.07e-05	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.16e-05	9.03e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NGFR—polycystic ovary syndrome	1.15e-05	8.93e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—GNAS—polycystic ovary syndrome	1.15e-05	8.93e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—POMC—polycystic ovary syndrome	1.14e-05	8.88e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PRL—polycystic ovary syndrome	1.14e-05	8.85e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.14e-05	8.85e-05	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.14e-05	8.85e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—TH—polycystic ovary syndrome	1.14e-05	8.83e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	1.13e-05	8.77e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ATF1—polycystic ovary syndrome	1.13e-05	8.76e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	1.13e-05	8.74e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.13e-05	8.74e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—TH—polycystic ovary syndrome	1.11e-05	8.65e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	1.11e-05	8.64e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—TH—polycystic ovary syndrome	1.11e-05	8.63e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	1.11e-05	8.61e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.11e-05	8.6e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	1.11e-05	8.59e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.1e-05	8.54e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	1.1e-05	8.54e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.1e-05	8.53e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.1e-05	8.53e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—NCOR1—polycystic ovary syndrome	1.1e-05	8.51e-05	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.1e-05	8.5e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	1.08e-05	8.41e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.08e-05	8.4e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	1.08e-05	8.4e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	1.08e-05	8.39e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	1.08e-05	8.37e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.08e-05	8.35e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	1.08e-05	8.34e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.07e-05	8.33e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	1.07e-05	8.29e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	1.07e-05	8.27e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.06e-05	8.23e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.06e-05	8.2e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	1.06e-05	8.18e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—TH—polycystic ovary syndrome	1.05e-05	8.15e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.04e-05	8.09e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NGFR—polycystic ovary syndrome	1.04e-05	8.09e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	1.04e-05	8.07e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—CYP1A1—polycystic ovary syndrome	1.04e-05	8.07e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.04e-05	8.04e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—POMC—polycystic ovary syndrome	1.04e-05	8.04e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PRL—polycystic ovary syndrome	1.03e-05	8.01e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	1.03e-05	7.97e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—SLC2A4—polycystic ovary syndrome	1.02e-05	7.93e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	1.02e-05	7.93e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	1.02e-05	7.91e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	1.02e-05	7.89e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	1.01e-05	7.83e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—GNAS—polycystic ovary syndrome	1e-05	7.79e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	9.96e-06	7.72e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.96e-06	7.72e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	9.94e-06	7.71e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	9.87e-06	7.66e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	9.86e-06	7.64e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	9.83e-06	7.63e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	9.81e-06	7.61e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.8e-06	7.6e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	9.75e-06	7.56e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	9.7e-06	7.52e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—MTHFR—polycystic ovary syndrome	9.7e-06	7.52e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.68e-06	7.51e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—TH—polycystic ovary syndrome	9.64e-06	7.47e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CYP19A1—polycystic ovary syndrome	9.61e-06	7.46e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	9.58e-06	7.43e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.57e-06	7.42e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	9.41e-06	7.29e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NRG1—polycystic ovary syndrome	9.39e-06	7.28e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	9.37e-06	7.27e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	9.29e-06	7.21e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	9.29e-06	7.2e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	9.21e-06	7.14e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	9.14e-06	7.09e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	9.14e-06	7.09e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	9.11e-06	7.06e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	9.1e-06	7.06e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—GNAS—polycystic ovary syndrome	9.09e-06	7.05e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	9.08e-06	7.04e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	9.06e-06	7.03e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	8.85e-06	6.87e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	8.81e-06	6.84e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	8.78e-06	6.81e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	8.67e-06	6.72e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.66e-06	6.72e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	8.65e-06	6.71e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—TH—polycystic ovary syndrome	8.6e-06	6.67e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	8.58e-06	6.65e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	8.5e-06	6.59e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	8.44e-06	6.54e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—TH—polycystic ovary syndrome	8.4e-06	6.51e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	8.39e-06	6.51e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8.39e-06	6.5e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	8.37e-06	6.49e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	8.33e-06	6.46e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	8.33e-06	6.46e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.27e-06	6.42e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	8.22e-06	6.37e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	8.2e-06	6.36e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	8.17e-06	6.34e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	8.17e-06	6.33e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	8.14e-06	6.32e-05	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—IL6—polycystic ovary syndrome	8.05e-06	6.24e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	8.04e-06	6.24e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	7.91e-06	6.14e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	7.89e-06	6.12e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	7.87e-06	6.1e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	7.87e-06	6.1e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	7.87e-06	6.1e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	7.87e-06	6.1e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PPARG—polycystic ovary syndrome	7.86e-06	6.1e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—TH—polycystic ovary syndrome	7.84e-06	6.08e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	7.82e-06	6.07e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—POMC—polycystic ovary syndrome	7.75e-06	6.01e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	7.75e-06	6.01e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—INS—polycystic ovary syndrome	7.71e-06	5.98e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	7.7e-06	5.97e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	7.68e-06	5.96e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	7.66e-06	5.94e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	7.65e-06	5.93e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	7.63e-06	5.92e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	7.49e-06	5.81e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	7.28e-06	5.65e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	7.26e-06	5.63e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	7.24e-06	5.61e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	7.22e-06	5.6e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	7.17e-06	5.56e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	7.12e-06	5.53e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	7.1e-06	5.51e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	7.03e-06	5.45e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	7.02e-06	5.45e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	7.02e-06	5.45e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	6.85e-06	5.32e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	6.78e-06	5.26e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	6.76e-06	5.24e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	6.72e-06	5.21e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—TH—polycystic ovary syndrome	6.7e-06	5.2e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	6.69e-06	5.19e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	6.62e-06	5.14e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	6.53e-06	5.06e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	6.52e-06	5.06e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	6.51e-06	5.05e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	6.5e-06	5.04e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	6.5e-06	5.04e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	6.46e-06	5.01e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	6.43e-06	4.99e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	6.4e-06	4.97e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	6.36e-06	4.93e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	6.34e-06	4.92e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	6.34e-06	4.92e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	6.26e-06	4.85e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—INS—polycystic ovary syndrome	6.22e-06	4.83e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	6.21e-06	4.82e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	6.2e-06	4.81e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	6.19e-06	4.8e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.18e-06	4.79e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	6.15e-06	4.77e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	6.13e-06	4.75e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	6.13e-06	4.75e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	6.12e-06	4.75e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	6.12e-06	4.74e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	6.1e-06	4.73e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—INS—polycystic ovary syndrome	6.09e-06	4.73e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	6.09e-06	4.72e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—INS—polycystic ovary syndrome	6.08e-06	4.72e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	6.07e-06	4.71e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.98e-06	4.64e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	5.91e-06	4.58e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	5.89e-06	4.57e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	5.88e-06	4.56e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	5.86e-06	4.54e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	5.83e-06	4.52e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	5.78e-06	4.48e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	5.78e-06	4.48e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	5.77e-06	4.48e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—INS—polycystic ovary syndrome	5.75e-06	4.46e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.59e-06	4.34e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	5.47e-06	4.24e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	5.44e-06	4.22e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	5.39e-06	4.18e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	5.37e-06	4.17e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	5.3e-06	4.11e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—INS—polycystic ovary syndrome	5.27e-06	4.09e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	5.21e-06	4.04e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.17e-06	4.01e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	5.03e-06	3.9e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	4.97e-06	3.86e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	4.94e-06	3.83e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	4.79e-06	3.72e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.73e-06	3.67e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	4.73e-06	3.67e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—INS—polycystic ovary syndrome	4.7e-06	3.65e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	4.68e-06	3.63e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—POMC—polycystic ovary syndrome	4.61e-06	3.58e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	4.61e-06	3.57e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—INS—polycystic ovary syndrome	4.59e-06	3.56e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	4.5e-06	3.49e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	4.41e-06	3.42e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	4.37e-06	3.39e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	4.35e-06	3.37e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	4.32e-06	3.35e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	4.31e-06	3.34e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—INS—polycystic ovary syndrome	4.29e-06	3.32e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.25e-06	3.29e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.22e-06	3.27e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.02e-06	3.12e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.85e-06	2.98e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.81e-06	2.96e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	3.74e-06	2.9e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	3.68e-06	2.86e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—INS—polycystic ovary syndrome	3.66e-06	2.84e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.55e-06	2.76e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	2.94e-06	2.28e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.88e-06	2.24e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.84e-06	2.2e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.83e-06	2.19e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	2.66e-06	2.06e-05	CbGpPWpGaD
